Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Niger Postgrad Med J ; 31(2): 139-146, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38826017

RESUMO

BACKGROUND: Physical exercise helps to mitigate cardiovascular risks in people with diabetes mellitus (DM), but there are limited data in Nigeria. This study aimed to assess cardiovascular risk awareness, exercise practices and metabolic outcomes among Nigerians with diabetes. MATERIALS AND METHODS: We conducted a cross-sectional study at five tertiary hospitals using questionnaire interviews and clinical assessments. Participants' knowledge of cardiovascular risk factors and knowledge of exercise were assessed on 12- and 5-item scores, while exercise practices were classed as adequate if performed regularly on 3 or more days weekly for a total of 150 min or more based on the American Diabetes Association recommendations. Mean body mass index (BMI), blood pressure (BP), fasting blood glucose, serum haemoglobin A1C (HbA1c), lipid profile, urea, creatinine and uric acid were then compared among participant groups. RESULTS: We studied 426 participants with DM, 58.7% females. The mean age was 52.9 ± 13.1 years, with males significantly older than females (54.6 ± 12.2 vs. 51.8 ± 13.5 years; 95% confidence interval: 0.27-5.28, P = 0.03). The mean age at diabetes diagnosis was 44.8 ± 11.7 years, and the median duration of diabetes was 84 months. There was low knowledge of cardiovascular risk factors and low knowledge of exercise (mean scores of 2.94 and 2.31, respectively). Forty-three per cent of participants reported adequate exercise, which was significantly associated with younger age (P = 0.007), male gender (P = 0.001) and formal education (P = 0.021). Participants with adequate exercise had lower systolic BP and serum urea compared to those with inadequate exercise, but there were no significant differences in BMI, fasting glucose, HbA1c, serum lipids, creatinine or uric acid. CONCLUSION: Participants had low knowledge of cardiovascular risks and the appropriate exercise practices for diabetes patients. There is a need for better patient education on diabetes self-care and exercise at clinic visits.


Assuntos
Doenças Cardiovasculares , Exercício Físico , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Estudos Transversais , Nigéria , Exercício Físico/fisiologia , Adulto , Doenças Cardiovasculares/prevenção & controle , Doenças Cardiovasculares/epidemiologia , Fatores de Risco de Doenças Cardíacas , Idoso , Hemoglobinas Glicadas/metabolismo , Hemoglobinas Glicadas/análise , Inquéritos e Questionários , Diabetes Mellitus/epidemiologia , Glicemia/metabolismo , Fatores de Risco , Índice de Massa Corporal
2.
Niger Postgrad Med J ; 26(1): 65-68, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30860202

RESUMO

Necrotising pneumonia (NP) is a rare complication of bacterial pneumonia which is associated with severe morbidity and mortality. Pneumonia of polymicrobial aetiology predicts worse pathology with fulminating clinical course. Reports of necrotising pneumonia from multiple bacterial infections are scanty in published literature. We report a case of a toddler with NP in whom Klebsiella pneumonia and Staphylococcus aureus, two pathogens which are well documented in its aetiopathogenesis, were isolated concurrently from his sputum and blood. Severe pneumonia, which shows slow response to recommended antibiotics treatment, should raise the suspicion of NP and possibly one of the polymicrobial origins. Even in resource-constrained settings, prompt institution of antibiotics and supportive care can result in resolution of pulmonary lesions.


Assuntos
Antibacterianos/uso terapêutico , Klebsiella pneumoniae/isolamento & purificação , Pneumonia Bacteriana/diagnóstico , Pneumonia Necrosante/diagnóstico , Staphylococcus aureus/isolamento & purificação , Pré-Escolar , Humanos , Nigéria , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia Bacteriana/microbiologia , Pneumonia Necrosante/tratamento farmacológico , Pneumonia Necrosante/microbiologia , Escarro/microbiologia
3.
Int J Mycobacteriol ; 12(1): 77-81, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36926767

RESUMO

Background: The burden of tuberculosis (TB) in Nigeria remains high, and diagnosis in children, a challenge. We aimed to document yield from Xpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) as a mode of diagnosis for children and the variables associated with a positive result. Methods: This was a retrospective review of TB treatment cards of children aged 0-15 years managed from January 2017 to December 2021 across six public tertiary institutions in Nigeria. The data obtained were analyzed using the descriptive and inferential statistics. Statistical significance was set at P < 0.05. Results: Of 1489 children commenced on TB treatment, 1463 (97.9%) had sufficient data for analysis the median age of study participants was 60 months (interquartile range [IQR]: 24, 120), and 814 (55.6%) were males. Xpert MTB/RIF test was performed in 862 (59%) participants and MTB was detected in 171 (19.8%) participants, of which 6.4% (11/171) had RIF resistance reported. The use of Xpert MTB/RIF rose from 56.5% in 2017 to 64% in 2020 but fell to 60.9% in 2021. We found that older age (> 10 years), the presence of pulmonary TB (PTB), and a negative human immunodeficiency virus (HIV) status were associated with positive Xpert MTB/RIF tests (P = 0.002, 0.001, and 0.012, respectively). Conclusion: The utilization of Xpert MTB/RIF in children increased in the years before the COVID-19 pandemic. Factors associated with MTB detection by Xpert MTB/RIF include older age, the presence of PTB, and a negative HIV status. Clinical and radiological evaluation continues to play vital roles in the diagnosis of childhood TB in Nigeria.


Assuntos
Antibióticos Antituberculose , COVID-19 , Infecções por HIV , Mycobacterium tuberculosis , Tuberculose , Masculino , Humanos , Criança , Pré-Escolar , Feminino , Rifampina/farmacologia , Rifampina/uso terapêutico , Mycobacterium tuberculosis/genética , Estudos Retrospectivos , Antibióticos Antituberculose/farmacologia , Antibióticos Antituberculose/uso terapêutico , Pandemias , Farmacorresistência Bacteriana , Sensibilidade e Especificidade , Tuberculose/diagnóstico , Tuberculose/epidemiologia , Tuberculose/complicações , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Escarro/microbiologia , Teste para COVID-19
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA